Jinsheng Yu

Medicine & Life Sciences

1. 3C proteases 18%
2. angiotensin converting enzyme 2 16%
3. Astrocytoma 49%
4. Carboxylic Ester Hydrolases 18%
5. Child 16%
6. Colorectal Neoplasms 100%
7. Comparative Genomic Hybridization 17%
8. Coronavirus 19%
9. Coronavirus Infections 22%
10. Cyclooxygenase 1 14%
11. DNA 20%
12. DNA Repair 20%
13. Drug Therapy 22%
14. Ferredoxins 17%
15. Fluorouracil 30%
16. Gene Expression 20%
17. Gene Expression Profiling 36%
18. Gene Regulatory Networks 14%
19. Genes 49%
20. Hemangioblasts 18%
21. Heterophile Antibodies 16%
22. human ACE protein 21%
23. Immunoassay 22%
24. Infectious Mononucleosis 14%
25. Interferons 24%
26. Irinotecan 28%
27. K-18 conjugate 14%
28. Neoplasms 59%
29. Neurofibrosarcoma 15%
30. Peripartum Period 14%
31. Peripheral Blood Stem Cells 14%
32. Pharmacogenetics 65%
33. plerixafor octahydrochloride 16%
34. Pneumonia 19%
35. Pregnane X Receptor 16%
36. Protein Deficiency 14%
37. Proteomics 30%
38. RNA 44%
39. SARS Virus 33%
40. selenomethylselenocysteine 20%
41. Severe Acute Respiratory Syndrome 28%
42. Single Nucleotide Polymorphism 21%
43. Technology 16%
44. Thymidylate Synthase 29%
45. Tissue Donors 15%
46. Transcriptome 29%
47. Transgenic Mice 24%
48. Virus Diseases 30%
49. Viruses 17%
50. West Nile virus 14%